FDA Enforcement Class II Terminated

Dimension Vista Lactate Dehydrogenase (LDI) Flex reagent cartridge, an in vitro diagnostic test for the quantitative measurement of lactate dehydrogenase in human serum and plasma on the Dimension Vista¿ System.Cat. No. K2054, Mat. No. 10464323

Recall: Z-0499-2019 · Reported December 5, 2018

Enforcement

Recall Number
Z-0499-2019
Event ID
81433
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Siemens Healthcare Diagnostics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 5, 2018
Initiation Date
October 11, 2018
Classification Date
November 27, 2018
Termination Date
June 29, 2020
Address
500 Gbc Dr Ms 514, N/A, Newark, DE, 19702-2466, United States

Description

Dimension Vista Lactate Dehydrogenase (LDI) Flex reagent cartridge, an in vitro diagnostic test for the quantitative measurement of lactate dehydrogenase in human serum and plasma on the Dimension Vista¿ System.Cat. No. K2054, Mat. No. 10464323

Reason

Siemens Healthcare Diagnostics has confirmed that Dimension Vista Lactate Dehydrogenase (LDI) may exhibit an erroneously elevated result when the preceding assay in the reaction cuvette is Lactic Acid (LA). The magnitude of the elevation may be variable. Both quality control and patient samples may be impacted. Incomplete removal of residual lactate dehydrogenase, a component of the LA reagent, has been identified as the cause of the potentially elevated result. A falsely elevated result for lactate dehydrogenase may lead to additional investigations to determine the etiology of tissue damage. Results would be correlated with clinical history and presentation in addition to other diagnostic laboratory testing.

Code Info

18240BA 18199BA 18162AC 18155BB 18106BC 18073BE 18036BC 17342BA

Distribution

Worldwide-domestic nationwide and foreign distribution.

Quantity

13435